Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy

BACKGROUND: The effective therapies for oral cancer patients of stage III and IV are generally surgical excision and radiation combined with adjuvant chemotherapy using 5-Fu and Cisplatin. However, the five-year survival rate is still less than 30% in Taiwan. Therefore, evaluation of effective drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ying-Ray, Wu, Wei-Ching, Ji, Wen-Tsai, Chen, Jeff Yi-Fu, Cheng, Ya-Ping, Chiang, Ming-Ko, Chen, Hau-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299600/
https://www.ncbi.nlm.nih.gov/pubmed/22283874
http://dx.doi.org/10.1186/1423-0127-19-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299600/
https://www.ncbi.nlm.nih.gov/pubmed/22283874
http://dx.doi.org/10.1186/1423-0127-19-9

Ejemplares similares